IP Library Granted Patent US 9,617,228
Granted Patent B2
US 9,617,228 · App. 14/996,801 · Granted Apr 11, 2017

Oligomer-containing substituted aromatic triazine compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,617,228
App. No.
14/996,801
Granted
Apr 11, 2017
Kind
B2
Abstract

The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.

Claims (26)

1. A compound of the structure:

or pharmaceutically acceptable salt thereof;

wherein n is , 3, 4, 5, 6, 7, 8, 9, 10, or 11.

2. The compound of claim 1 , wherein n is 2.

3. The compound of claim 1 , wherein n is 3.

4. The compound of claim 1 , wherein n is 4.

5. The compound of claim 1 , wherein n is 5.

6. The compound of claim 1 , wherein n is 6.

7. The compound of claim 1 , wherein n is 7.

8. The compound of claim 1 , wherein n is 8.

9. The compound of claim 1 , wherein n is 9.

10. The compound of claim 1 , wherein n is 10.

11. The compound of claim 1 , wherein n is 11.

12. A composition comprising a compound of the structure:

or pharmaceutically acceptable salt thereof;

wherein n is 3, 4, 5, 6, 7, 8, 9, 10, or 11.

13. The composition of claim 12 , wherein n is 2.

14. The composition of claim 12 , wherein n is 3.

15. The composition of claim 12 , wherein n is 4.

16. The composition of claim 12 , wherein n is 5.

17. The composition of claim 12 , wherein n is 6.

18. The composition of claim 12 , wherein n is 7.

19. The composition of claim 12 , wherein n is 8.

20. The composition of claim 12 , wherein n is 9.

21. The composition of claim 12 , wherein n is 10.

22. The composition of claim 12 , wherein n is 11.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
SECURITY INTEREST Recorded Mar 15, 2016
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS A COLLATERAL AGENT
Reel/Frame 037990/0511 →